Literature DB >> 30402738

[Arterial hypertension in old age with the focus on 80].

Dhayana Dallmeier1,2, Michael D Denkinger3,4.   

Abstract

Untreated high blood pressure in old age increases the risk of secondary diseases, especially stroke, coronary heart disease, myocardial infarction and heart failure and should be treated according to the guidelines. For slightly frail people up to the age of 80 years, a systolic blood pressure of 130-139 mm Hg (measured in the doctors surgery) should be the aim. According to the current European guidelines the same values are recommended for those over the age of 80 years but treatment should start at a systolic blood pressure of ≥160 mm Hg. In physically disabled and very frail older people an individually tailored approach is recommended, regardless of age. The authors recommend a target systolic value <150 mm Hg but not below 130/70 mm Hg. In the event of poor tolerance the treatment should be adapted further as necessary. Antihypertensive medication should be selected under the aspects of polypharmacy. In many cases arterial hypertension in old age can be treated in accordance with the guidelines, taking multimorbidity and the interaction of medications into consideration.

Entities:  

Keywords:  Blood pressure; Blood pressure determination; Disability; Frailty; Physical function

Mesh:

Substances:

Year:  2018        PMID: 30402738     DOI: 10.1007/s00391-018-1454-0

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  43 in total

Review 1.  Management of blood pressure for acute and recurrent stroke.

Authors:  Venkatesh Aiyagari; Philip B Gorelick
Journal:  Stroke       Date:  2009-04-23       Impact factor: 7.914

Review 2.  A review of the etiology, associated comorbidities, and treatment of orthostatic hypotension.

Authors:  Lawrence C Perlmuter; Garima Sarda; Vanessa Casavant; Aron D Mosnaim
Journal:  Am J Ther       Date:  2013 May-Jun       Impact factor: 2.688

3.  Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents: The PARTAGE Study.

Authors:  Athanase Benetos; Carlos Labat; Patrick Rossignol; Renaud Fay; Yves Rolland; Filippo Valbusa; Paolo Salvi; Mauro Zamboni; Patrick Manckoundia; Olivier Hanon; Sylvie Gautier
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

4.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors: 
Journal:  N Engl J Med       Date:  2017-12-21       Impact factor: 91.245

Review 5.  Antihypertensive drug therapy in older patients.

Authors:  J G Wang; J A Staessen
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

6.  Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative.

Authors:  Laura D Carbone; Karen C Johnson; Andrew J Bush; John Robbins; Joseph C Larson; Asha Thomas; Andrea Z LaCroix
Journal:  Arch Intern Med       Date:  2009-01-26

7.  Definitions and characteristics of sodium sensitivity and blood pressure resistance.

Authors:  M H Weinberger; J Z Miller; F C Luft; C E Grim; N S Fineberg
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

8.  Treatment of hypertension in an elderly outpatient population in the Netherlands.

Authors:  Linda R Tulner; Ingeborg M J A Kuper; Jos P C M van Campen; Cornelis H W Koks; Melvin R Mac Gillavry; Jos H Beijnen; Desiderius P M Brandjes
Journal:  Am J Geriatr Pharmacother       Date:  2009-08

Review 9.  Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis.

Authors:  Anna Angelousi; Nicolas Girerd; Athanase Benetos; Luc Frimat; Sylvie Gautier; Georges Weryha; Jean-Marc Boivin
Journal:  J Hypertens       Date:  2014-08       Impact factor: 4.844

Review 10.  Drug interactions and drugs that affect blood pressure.

Authors:  William J Elliott
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.